Satoshi Deyama, Eunyoung Bang, Taro Kato, Xiao-Yuan Li, Ronald S Duman. Biol Psychiatry 2019
Times Cited: 51
Times Cited: 51
Miyeon Choi, Seung Hoon Lee, Ho Lee Chang, Hyeon Son. Biochim Biophys Acta 2016
Times Cited: 24
Times Cited: 24
List of shared articles
Times cited
[Resolvins as novel targets for rapid-acting antidepressants].
Satoshi Deyama. Nihon Yakurigaku Zasshi 2020
Satoshi Deyama. Nihon Yakurigaku Zasshi 2020
Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
Satoshi Deyama, Ronald S Duman. Pharmacol Biochem Behav 2020
Satoshi Deyama, Ronald S Duman. Pharmacol Biochem Behav 2020
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Kenji Hashimoto. Psychiatry Clin Neurosci 2019
Kenji Hashimoto. Psychiatry Clin Neurosci 2019
Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression.
Wei Zheng, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Bin Zhang, Su-Miao Zhou, Su Yan, Ming-Zhe Yang, Sha Nie, Yu-Ping Ning. Ther Adv Psychopharmacol 2021
Wei Zheng, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Bin Zhang, Su-Miao Zhou, Su Yan, Ming-Zhe Yang, Sha Nie, Yu-Ping Ning. Ther Adv Psychopharmacol 2021
Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine.
Satoshi Deyama, Katsuyuki Kaneda. Neuropharmacology 2023
Satoshi Deyama, Katsuyuki Kaneda. Neuropharmacology 2023
Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants.
Ronald S Duman, Satoshi Deyama, Manoela Viar Fogaça. Eur J Neurosci 2021
Ronald S Duman, Satoshi Deyama, Manoela Viar Fogaça. Eur J Neurosci 2021
Antidepressant-like effects of trophic factor receptor signaling.
Monica Sathyanesan, Samuel S Newton. Front Mol Neurosci 2022
Monica Sathyanesan, Samuel S Newton. Front Mol Neurosci 2022
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression.
Wei Zheng, Li-Mei Gu, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Bin Zhang, Hai-Shan Shi, Dan-Feng Wang, Yu-Ping Ning. Front Psychiatry 2021
Wei Zheng, Li-Mei Gu, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Bin Zhang, Hai-Shan Shi, Dan-Feng Wang, Yu-Ping Ning. Front Psychiatry 2021
Resolvins as potential candidates for the treatment of major depressive disorder.
Satoshi Deyama, Masabumi Minami, Katsuyuki Kaneda. J Pharmacol Sci 2021
Satoshi Deyama, Masabumi Minami, Katsuyuki Kaneda. J Pharmacol Sci 2021